Lambert-Eaton myasthenic syndrome - Tumor versus nontumor forms

被引：45

作者：

Titulaer, Maarten J. ^{[1
]}

Verschuuren, Jan J. G. M. ^{[1
]}

机构：

[1] Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands

来源：

MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE | 2008年 / 1132卷

关键词：

Lambert-Eaton myasthenic syndrome; small cell lung cancer; smoking; HLA;

D O I：

10.1196/annals.1405.030

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Half the patients with Lambert-Eaton myasthenic syndrome (LEMS) have a small cell lung carcinoma (SCLC). SCLC is an aggressive tumor and survival is poor. We studied the differences between LEMS patients with and without an SCLC. Several items were identified, among which are age, smoking behavior, sex, the progression of clinical symptoms, HLA, and presence of Sox1 serum antibodies. The relationship between these parameters is not fully elucidated. Data support a role for the LEMS-related immune response in suppressing the tumor activity. We summarize the literature and present data from our Dutch cohort of 104 LEMS patients to compare the clinical and laboratory characteristics of tumor and nontumor related LEMS patients.

引用

页码：129 / 134

页数：6

共 31 条

[11] Seronegative Lambert-Eaton myasthenic syndrome [J].

Nakao, YK ;

Motomura, M ;

Fukudome, T ;

Fukuda, T ;

Shiraishi, H ;

Yoshimura, T ;

Tsujihata, M ;

Eguchi, K .

NEUROLOGY, 2002, 59 (11) :1773-1775

[12] MOLECULAR DIVERSITY OF NEURONAL-TYPE CALCIUM CHANNELS IDENTIFIED IN SMALL-CELL LUNG-CARCINOMA [J].

OGUROOKANO, M ;

GRIESMANN, GE ;

WIEBEN, ED ;

SLAYMAKER, SJ ;

SNUTCH, TP ;

LENNON, VA .

MAYO CLINIC PROCEEDINGS, 1992, 67 (12) :1150-1159

[13] THE LAMBERT-EATON MYASTHENIC SYNDROME - A REVIEW OF 50 CASES [J].

ONEILL, JH ;

MURRAY, NMF ;

NEWSOMDAVIS, J .

BRAIN, 1988, 111 :577-596

[14]

Paesmans M, 2000, CANCER-AM CANCER SOC, V89, P523, DOI 10.1002/1097-0142(20000801)89:3<523::AID-CNCR7>3.0.CO

[15]

2-6

[16] Increased frequency of HLA class II alleles DRB1*0301 and DQB1*0201 in Lambert-Eaton myasthenic syndrome without associated cancer [J].

Parsons, KT ;

Kwok, WW ;

Gaur, LK ;

Nepom, GT .

HUMAN IMMUNOLOGY, 2000, 61 (08) :828-833

[17]

PORTHA C, 1983, SEM HOP PARIS, V59, P1337

[18] MYASTHENIC SYNDROME (EATON-LAMBERT SYNDROME) ASSOCIATED WITH PULMONARY ADENOCARCINOMA [J].

RAMOSYEO, YL ;

REYES, CV .

JOURNAL OF SURGICAL ONCOLOGY, 1987, 34 (04) :239-242

[19] PARA-NEOPLASTIC MYASTHENIC SYNDROME IGG INHIBITS CA-45(2+) FLUX IN A HUMAN SMALL CELL-CARCINOMA LINE [J].

ROBERTS, A ;

PERERA, S ;

LANG, B ;

VINCENT, A ;

NEWSOMDAVIS, J .

NATURE, 1985, 317 (6039) :737-739

[20] SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome [J].

Sabater, L. ;

Titulaer, M. ;

Saiz, A. ;

Verschuuren, J. ;

Guere, A. O. ;

Graus, F. .

NEUROLOGY, 2008, 70 (12) :924-928

← 1 2 3 4 →